An amplification-free, 16S rRNA test for Neisseria gonorrhoeae in urine (original) (raw)
* Corresponding authors
a Chemical and Biomolecular Engineering, University of California, Los Angeles, Los Angeles, CA 90095, USA
E-mail: hmonbouq@ucla.edu
b Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA
c Bioengineering, University of California, Los Angeles, Los Angeles, CA 90095, USA
Abstract
An amplification-free, nanopore-based nucleic acid detection platform has been demonstrated for rapid, 16S rRNA sequence-specific detection of Neisseria gonorrhoeae at 10–100 CFU mL−1 in human urine against background bacterial flora at 1000 CFU mL−1. Gonorrhea is a very common notifiable communicable disease, antibiotic resistant strains have emerged, and the rate of reported gonococcal infections continues to increase. Since rapid clinical identification of bacterial pathogens in clinical samples is needed to guide proper antibiotic treatment and to control disease spread, it is important to engineer rapid, sensitive, selective, and inexpensive point-of-care (POC) diagnostic devices for pathogens such as N. gonorrhoeae. Our detector technology is based on straightforward conductometric detection of sustained blockage of a glass nanopore. Charge neutral, complementary peptide nucleic acid probes are conjugated to polystyrene beads to capture N. gonorrhoeae 16S rRNA selectively. In the presence of an electric field applied externally through a glass nanopore, the PNA-microbead conjugates that acquire substantial negative charge upon target hybridization are driven to the smaller diameter nanopore. At least partial blockage of the nanopore results in a sustained drop in ionic current that can be measured easily with simple electronics. The ability to detect N. gonorrhoeae over the range of 10 to 100 CFU mL−1 spiked in human urine was demonstrated successfully with estimated sensitivity and specificity of ∼98% and ∼100%, respectively. No false positives were observed for the control group of representative background flora (E. coli, K. pneumoniae, and E. faecalis) at 1000 CFU mL−1. Also, N. gonorrhoeae at 50 CFU mL−1 was successfully detected against 1000 CFU mL−1 of background flora in urine. These results suggest that this amplification-free technology may serve as the basis for rapid, inexpensive, low-power detection of pathogens in clinical samples at the POC.
This article is Open Access
Please wait while we load your content... Something went wrong. Try again?
Associated articles
Article information
DOI
https://doi.org/10.1039/D2SD00128D
Article type
Paper
Submitted
22 Jul 2022
Accepted
03 Nov 2022
First published
11 Nov 2022
This article is Open Access
Download Citation
Sens. Diagn., 2023,2, 163-167
Permissions
An amplification-free, 16S rRNA test for Neisseria gonorrhoeae in urine
Z. Zheng, Y. Cao, S. Chandrasekaran, J. J. Schmidt, O. B. Garner and H. G. Monbouquette,Sens. Diagn., 2023, 2, 163DOI: 10.1039/D2SD00128D
This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.
To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.